More importantly, ERBB2 knockdown significantly reversed the roles of miR-488 inhibition in pancreatic tumor cell lines, indicating that miR-488 exerts atumor-suppressive effect on pancreatic carcinoma through targeting ERBB2 to modulate the cancer cell cycle. Here, ERBB2 is linked to exocrine pancreatic carcinoma.